Navigation Links
Frantz Medical Group Announces the Promotion of Stephanie Harrington to Chief Operating Officer
Date:5/9/2011

CLEVELAND, May 9, 2011 /PRNewswire/ -- Mentor, Ohio-based Frantz Medical Group announced the immediate promotion of Stephanie A. S. Harrington, M.S. to Chief Operating Officer.  Ms. Harrington joined Frantz Medical Group in 2005 as Vice President, Research & Business Development. Since that time, she has assumed increased responsibilities such as direct management of regulatory affairs and quality assurance, manufacturing and molding/tool room operations. Ms. Harrington has also served as the Chief Operating Officer for VasoStar (cardiovascular minimally invasive device to open arterial blockages), CardioStar (non-invasive blood pressure monitor) and NanoMed (cardiovascular stent surface technology), and the Vice President of Merlot Orthopedics (orthopedic fixation devices).  Each of these companies is a Frantz Medical joint venture/equity company, and she will continue to directly manage these various operations.

Ms. Harrington is a Chemical Engineer with an undergraduate degree from the University of Maryland, and graduate degree from Stanford University.  She has been focused in the medical device field for the past 16 years with extensive experience in new product development, regulatory affairs and quality assurance. She has previously held senior management positions at Imalux and STERIS.

Ms. Harrington has spearheaded the cardiovascular and orthopedic R&D initiatives at Frantz Medical Group, including industrial-sponsored and state and national funded research grants with leading institutional partners such as Cleveland Clinic, Global Cardiovascular Innovation Center, Stanford University, and University of Virginia. Ms. Harrington will be involved in all operational aspects for the Frantz Medical Group of companies, including Frantz Tool & Design, and will serve as an advisor for tactical and strategic input on Frantz Medical Group's bioscience seed initiatives.

"I highly value Stephanie's input and leadership in all aspects of our operations, and look forward to her even further expanded role as my colleague in Frantz Medical Group," said Mark G. Frantz, Chairman and CEO.

About Frantz Medical Group

Frantz Medical Group (FMG) has been transforming innovative concepts into commercially successful medical devices, both electromechanical and disposable products, since 1979.   As an ISO 13485-certified, FDA-registered medical device company, FMG offers inventors and early-stage companies the infrastructure to design, verify, and transfer to production new medical devices efficiently and cost-effectively.   FMG's manufacturing capabilities include high-volume injection molding, assembly, inspection, and packaging – with both clean room and open manufacturing areas.   For high volume products, FMG designs products for later-stage automation, and has implemented in-house automation, lowering labor requirements and per-piece costs.

For further information regarding Frantz Medical Group, please refer to the website: www.frantzgroup.com.


'/>"/>
SOURCE Frantz Medical Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Moffitt Cancer Center Signs Licensing Agreement with Frantz BioMarkers, LLC
2. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
3. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Globus Medical Raises $110 Million in Series E Financing Round
6. Quark Pharmaceuticals Appoints New Chief Medical Officer
7. Boston University Biomedical Engineers Find Chink in Bacterias Armor
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
10. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
11. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... OTTAWA, Ontario , June 27, 2016  VMS ... the Company,s Board will take whatever measures required to ... the Company,s stock which is currently listed on the ... S Wexler, Company Chairman and CEO, "We are seeing ... be difficult to understand, not only by the Company, ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... The Academy of Managed Care Pharmacy (AMCP) ... would allow biopharmaceutical companies to more easily share health ... and coverage decisions, a move that addresses the growing ... The recommendations address restrictions in the sharing of ... label, a prohibition that hinders decision makers from accessing ...
Breaking Medicine Technology:
(Date:6/26/2016)... Battle Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... abuse, joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table ... held in honor of the city’s history as home to some of the world’s ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... they have been diagnosed with endometriosis. These women need a treatment plan to ... a comprehensive approach that can help for preservation of fertility and ultimately achieving ...
(Date:6/25/2016)... , ... June 25, 2016 , ... Austin residents seeking ... American College of Mohs Surgery and to Dr. Russell Peckham for medical and surgical ... effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
Breaking Medicine News(10 mins):